MOSCOW, April 10. /TASS/. The Russian government will allocate 387 mln rubles ($4.8 mln) for the launch of the production of the Mir-19 anti-coronavirus drug. A respective decree has been signed by Prime Minister Mikhail Mishustin, the press service of the cabinet said in a statement on Sunday.
"As much as 387 mln rubles will be allocated for the upgrade of technological lines required for the mass production of the Mir-19 coronavirus drug. Prime Minister Mikhail Mishustin has signed a respective decree," the statement said.
The Russian health ministry registered Mir-19 on December 22. The drug was developed by Russia’s Federal Medical Biological Agency to prevent and treat coronavirus infection via pulmonary or intranasal administration. It stops the virus from replicating and prevents the most severe forms of the disease, as well as pneumonitis and acute respiratory distress syndromes, according to the agency.